Additional Information

Description

A multidrug screening system designed for rapid urinalysis integrates a twelve-panel configuration to detect a broad spectrum of drug metabolites through lateral flow chromatographic immunoassay. The cup structure supports direct sample collection, allowing immediate activation without secondary handling steps. Integrated adulterant detection for creatinine, nitrite, oxidants, pH, and specific gravity strengthens specimen integrity assessment within the same device.

The enclosed immunoassay membrane provides qualitative results through visually interpreted indicator lines, enabling simultaneous evaluation of amphetamines, barbiturates, benzodiazepines, cocaine metabolites, methamphetamines, MDMA, methadone, opiates (300 ng/mL), oxycodone, phencyclidine, tricyclic antidepressants, and tetrahydrocannabinol. The configuration supports stable reagent performance, ensuring consistent signal development within a five-minute window.

Structural components include a sealed test cup with tamper-evident security features, allowing controlled handling in clinical and occupational screening environments. Visual result windows maintain clarity during migration, while the internal reagent matrix is calibrated to CLIA-waived criteria for point-of-care testing. Sample contamination safeguards assist in determining the validity of each specimen by identifying abnormal chemical conditions.